Related Experiment Video
Updated: Aug 20, 2026
Single-cell Gene Expression Profiling Using FACS and qPCR with Internal Standards
Published on: February 25, 2017
Comparative analysis of imbalances in genomic DNA and mRNA expression levels in chondrosarcoma-derived cell line
C M Schörle1, I Verdorfer, F Finger
1Cartilage Research, Department of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany.
Abstract:
Malignant cell transformation results from multiple biological alterations including chromosomal abnormalities, oncogene activation, loss of suppressor gene function and a imbalance in cell regulating processes. The aim of our study was to combine gene expression and genomic analysis to evaluate the cellular phenotype of a chondrosarcoma cell line, which is potentially a useful in vitro model system for physiological and/or neoplastic chondrocytes. cDNA-array, quantitative PCR and comparative genomic hybridization (CGH) technologies were used to analyze gene expression profiles of chondrosarcoma cell line FSCP-1 in correlation to changes of DNA copy number on corresponding chromosomal sections. Gene expression analysis revealed similarities, but also great differences in between the chondrosarcoma cell line and physiological chondrocytes. In particular the proliferative activity was up-regulated and molecules involved in matrix synthesis and turnover down-regulated. CGH analysis revealed a heterogeneous pattern of DNA gains or losses. The c-myc oncogene, located on 8q24.12-q24.13, was the only gene with a marked up-regulation located on a chromosome section with a gain of DNA copy number. The inability of the chondrosarcoma cell line FSCP-1 to maintain an adequate matrix turnover as well as a notable proliferative activity is similar to neoplastic chondrosarcoma in vivo. The limited correlation between the CGH analysis and the gene expression pattern supports the notion that also in neoplastic cells most genes are not primarily regulated by the gene dosage, but by cellular regulation pathways. However, genes such as c-myc might represent significant exceptions potentially relevant for the clinico-biological behavior of the neoplasms.
Insights
This study analyzed chondrosarcoma cell line FSCP-1, revealing increased proliferation and decreased matrix synthesis. The c-myc oncogene showed up-regulation linked to DNA copy number gain, suggesting its role in neoplastic chondrocytes.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Malignant transformation involves genetic and cellular alterations.
- Chondrosarcoma cell lines offer in vitro models for studying neoplastic chondrocytes.
Purpose of the Study:
- To combine gene expression and genomic analysis of the chondrosarcoma cell line FSCP-1.
- To evaluate the cellular phenotype and its correlation with DNA copy number changes.
Main Methods:
- Utilized cDNA-array, quantitative PCR, and comparative genomic hybridization (CGH).
- Analyzed gene expression profiles in correlation with DNA copy number variations.
Main Results:
- Chondrosarcoma cell line FSCP-1 exhibited up-regulated proliferative activity and down-regulated matrix synthesis molecules.
- CGH analysis showed heterogeneous DNA copy number alterations.
- The c-myc oncogene was significantly up-regulated on a chromosome section with DNA gain.
Conclusions:
- FSCP-1 cell line mimics neoplastic chondrosarcoma in vivo regarding matrix turnover and proliferation.
- Gene dosage may not be the primary regulator for most genes in neoplastic cells, with exceptions like c-myc.
- The c-myc oncogene's altered status may be clinically relevant for chondrosarcoma behavior.
